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ABSTRACT 
 
Zinc is an essential mineral that can cause pathological effects whether in excess or deficiency.  
Zinc is a component for over 250 enzymes and is required for cell growth, cell division, and cell 
function. Zinc is found in muscle and bones, with the prostrate, liver, skin, and kidney having 
detectable levels of zinc. However, zinc present in excess or deficiency can cause significant 
pathology in patients that include deleterious effects neurologically. Zinc in excess in vivo can 
cause focal neuronal pathology, while zinc deficiency can bring about mental lethargy, 
neuropsychiatric disorders, and reduced nerve conduction. Zinc is assimilated within the body by 
oral ingestion, dermal exposure, and pulmonary inhalation. Although not generally viewed as a 
cause of cancer, studies suggest that zinc is associated with progression of prostate malignancy. 
Toxic levels of zinc have been shown to induce lethargy, neurotoxicity, and gliotoxicity. High levels 
of zinc causes neuronal death in cortical cell tissue culture. Zinc is known to accumulate following 
the death of neurons in global ischemia. Therefore, zinc deficiency or excess is of significant 
clinical concern. 
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1. AN ESSENTIAL MINERAL 
 
Zinc is an element found in-group 12 of the 
periodic chart and is a transition metal (any 
element in the d-block of the periodic table). Zinc 
is an essential mineral, one of a total of 16, which 
includes [1]: calcium, phosphorus, potassium, 
sulfur, sodium, chloride, magnesium, iron, zinc, 
copper, manganese, iodine, and selenium, 
molybdenum, chromium, and fluoride. There are 
two types of minerals: macro-minerals and trace 
minerals. Macro-minerals are minerals required 
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for normal health in larger amounts than trace 
minerals. Macro-minerals include calcium, 
phosphorus, magnesium, sodium, potassium, 
and chloride. Zinc is an important mineral for 
many organisms and is known to be a 
component of more than 250 enzymes and a 
large number of proteins [1]. Therefore, zinc is 
profoundly important for normal human health. 
 
Of all the zinc found in the human body, almost 
90% are located in the bones and muscles of 
individuals [1]. The oral consumption of zinc is 
followed by absorption in the small intestines, 
followed by dissemination throughout the body, 
carried by serum where it is bound to proteins 
[1].  
 
Having noted the importance of zinc for human 
nutrition and health, it is necessary to address 
the reality that zinc deficiency or significant 
excess in the body results in pathological 
conditions. Zinc can play a strong role in 
neuronal death and participate in toxic events on 
the cellular level [1]. Zinc is believed to be 
associated with the regulation of apoptosis 
(death of cells that occurs as a normal and 
controlled part of an organism's development) at 
the cellular level [1].  
 
2. ZINC IN THE HUMAN BODY 
 
Almost 90% of the total amount of zinc found in 
the body (up to 3 grams total) is located in the 
bones and muscles [1]. Zinc is also found in the 
gastric intestines, brain, pancreas, skin, stomach, 
and kidney (see Fig. 1) [2,3]. Once in the serum, 
zinc is bound to proteins such as transferrin, α-
microglobin, and albumin [1]. 
 
 
 
Fig. 1. Disposition of zinc in the human body.  
Zinc is found in numerous organs, including 
the brain, bones and muscle 
 
Within the cell itself, it is generally accepted that 
50% of zinc present will be in the cytosol with 
somewhere from 30% to 40% contained in the 
nucleus [4]. The remaining balance is localized in 
the membranes [4]. In these locations, zinc plays 
an important role in nucleic acid and protein 
metabolism, as well as cell growth, function, and 
cell division [5]. Interestingly, the cellular zinc 
component is thought to play some role in 
homeostatic control that avoids the assimilation 
of excess zinc [1].  
 
3.  ZINC ASSIMILATION, NEUROLOGICAL 
AND OTHER EFFECTS 
 
The assimilation of zinc into the human body can 
be accomplished by three pathways. These three 
pathways are inhalation, oral ingestion, and 
absorption through skin [6]. The eventual effects, 
as a result of each type of assimilation, will be 
depend upon specific portions of the body within 
these pathways [6].   
 
Although there are pathological results of 
excessive uptake or deficiency, the oral ingestion 
of adequate zinc in nutrition is important for 
normal health [1]. The oral consumption of 
excessive amounts of zinc will quickly bring 
about noticeable nausea, vomiting, abdominal 
pain, and eventual anemia [7]. Subsequent 
effects originating from the central nervous 
system will include lethargy (pathological state of 
unresponsiveness, inactivity, and dizziness) [7].  
Further studies have shown that excessive oral 
ingestion will bring about overt symptoms such 
as fatigue and lethargy [8].   
 
Pulmonary inhalation of continuous/excessive 
amounts of zinc is shown to cause pathological 
issues.  Inhalation of zinc in the form of industrial 
originated zinc oxide will cause shakes and 
chills, sometimes referred to as metal fume fever 
or zinc shakes (illness primarily caused by 
exposure to chemicals such as zinc oxide)  [9]. 
Galvanization (applying zinc to other metals to 
prevent rust) is a process that can result in aerial 
exposure of zinc [1]. Particle sizes of less than 1 
micrometer can effectively introduce troubling 
levels of zinc into the body, with these exposures 
primarily originating from industrial settings [10]. 
Symptoms noticeable include fatigue, nausea, 
fever, chest pain, cough, dyspnea (difficult 
breathing), and muscle soreness [11].   
 
Concerning assimilation through the dermal 
layers, it is known that zinc is a common 
component of various topical treatments of 
various conditions, including of wounds that 
cause breaks within the skin [12]. However, the 
extent of zinc absorption is influenced by the pH 
of the skin, chemical speciation, and amount of 
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zinc applied from the medicament [13]. Overall, it 
is generally accepted that exposure to zinc 
through dermal pathways does not constitute a 
significant pathological risk [1]. 
 
Interestingly, the excess exposure to zinc derived 
from denture adhesives can induce copper 
deficiency leading to neurological symptoms 
involving walking and balance [14].  
Unfortunately, recovery from these neurological 
symptoms looks to be limited in extent and 
efficacy [14]. Alarmingly, other investigators have 
reported even more severe results of excess zinc 
exposure from denture fixative creams that 
include serious neurological effects such as 
degeneration of the spinal cord, crippling nerve 
damage such as human swayback disease, as 
well as bone marrow suppression [15].  
Swayback disease caused by excess zinc that 
induces a copper deficiency brings about 
neurological manifestations, including 
myelopathy (disease of the spinal cord), a 
spastic gait, and prominent sensory ataxia (loss 
of control) [15]. Copper deficiency, induced by 
zinc exposure in denture creams is shown to 
cause serious neurological disease [16]. 
 
Therefore, the assimilation of excess zinc as well 
as the deficiency thereof- induces various 
significant neurological related health maladies, 
these summarized in Table 1. These include 
lethargy, effects upon focal ability, and 
psychiatric conditions [1]. There are other 
notable health related risks associated with zinc 
assimilation. 
 
Certain metals have been associated with 
carcinogenicity (i.e. nickel, chromium) but zinc is 
generally not accepted to be a causative factor 
for cancer [1]. However, other studies of prostate 
adenocarcinoma, and particularly those 
monitoring the level of zinc in the surrounding 
tissues, indicate the potential involvement of zinc 
in the progression of prostrate malignancy 
[17,18].  
 
Even though there are homeostatic mechanisms 
preventing zinc from achieving a level in the 
brain that would cause pathological results, there 
are cases where neurological symptoms follow 
zinc intoxication [1]. One case relates how a 
young male child induced lethargy and focal 
neurological reduction following 72 hours after 
ingesting as much as 12 grams of metallic type 
zinc [19].  Previous studies have shown that zinc 
can function as a neuromodulator [20,21]. Other 
studies have demonstrated that zinc within the 
body could be a rapid and potent neurotoxin, as 
well as a gliotoxin [22,23,24]. Other substantial 
neural health issues will now be discussed.  
 
Previous studies have shown that an exposure to 
zinc at a level of 300 µM to 600 µM, for as little 
as 15 minutes, can induce extensive neuronal 
death in tissue culture of cortical cells [25]. Zinc 
has been shown to be active in neuronal 
damage, participates in action during membrane 
depolarization following acute brain injury to 
increase its neurotoxicity [26]. This membrane 
depolarization causes an increase effect of zinc 
to act as a neurotoxin [27].  
 
Other studies have described zinc as a 
necessary component of excito-toxic cascade 
following seizures, ischemia (inadequate blood 
supply to an organ, especially the heart 
muscles), and head related trauma [28,29].  
 
Damage to the brain regions out of broad 
ischemia to hippocampal CA1, thalamus, 
neocortex, and striatum have shown zinc 
accumulation among dying or dead neurons [30]. 
This event has also been shown to occur in the 
hippocampal hilar region [30]. The fact that this 
event described above can be prevented by 
intraventricular injection of zinc chelator calcium-
EDTA (Edetate Calcium Disodium) supports the 
assertion that zinc accumulation leads to 
neuronal cell death [31]. 
 
Previous studies have associated zinc to an 
oxidative stress type induction to neuron cell 
damage [32]. Inclusive is a study showing zinc-
induced neuron cell death occurring with the 
increased levels of reactive oxygen species 
within neurons [33]. Seen as a support for this 
scenario of zinc action on neurons, the zinc-
induced cell death is decreased by introduction 
of anti-oxidant agents [34]. 
 
Table 1. Effects caused by zinc deficiency and substantial excessive presence 
 
Condition/Pathology 
Zinc deficiency Zinc substantial excess 
Reduction of nerve conduction 
Lethargy due to mental effects 
Pathology of neurosensory ability 
Pathology of psychiatric ability 
Mental related lethargy 
Reduction of focal activity 
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A zinc-induced apoptosis event in neurons can 
take place by a pathway triggering caspase 
activation (and apoptosis) by induction of p75
NTR 
associated death executer and neutrophin 
receptor p75NTR [35,36].  
 
The release of intracellular zinc will initiate 
neuronal apoptosis [37,38], with accompanied 
cell swelling and destruction of intracellular 
organelles [39,37]. Altogether, these studies 
suggest that zinc-initiated neuronal cell death 
encompasses both apoptotic and necrotic 
mechanisms (cell injury, which results in the 
premature death of cells) [29]. 
 
Previous studies have shown the likelihood that 
zinc is involved in certain neurodegenerative 
diseases [40]. The improper regulation of zinc 
homeostasis and zinc may play a substantial role 
for the onset and progression of Alzheimer’s 
disease [40]. 
 
Other unfortunate cases include the fatal 
accidental over dose of zinc to a neonate 
following confusion of amounts of micrograms to 
milligrams [41]. A study conducted in Nepal 
showed that zinc phosphide occurred in 6.5% of 
all poison cases occurring in 2004 [42]. Also, 
acute intravenous zinc poisoning occurs from 
poor administration of parenteral nutrition with 
intravenous injection [43]. 
 
In addition to pathological conditions described 
above, symptoms from zinc deficiency such as 
growth retardation, skin changes, poor appetite, 
mental lethargy, taste abnormalities, slow wound 
healing have been noted in even moderate zinc 
deficiency [44]. The condition of zinc deficiency is 
aggravated by low dietary intake, alcohol abuse, 
malabsorption, and chronic renal disease [1,44]. 
Zinc deficiency is seen to be widespread and has 
a destructive impact on neuronal development, 
as well as immunity of the patient [1]. 
 
Therefore, it is seen that endogenous zinc can 
be substantially involved with cytotoxic actions in 
individual cells. Studies have shown that zinc has 
a notably activity in cell death occurring in the 
brain [1]. However, zinc is considered to be one 
of the essential minerals for human health.  The 
dual role that zinc plays in human health and 
clinical pathology deserves further study.  To 
understand the role zinc plays in pathological 
events is important, in order to determine a 
remedial course of treatment.  Therefore, the 
investigation will continue and elucidate 
important facets of zinc in the human body. 
4. CONCLUSION 
 
Endogenous zinc is known to have important 
involvement within cytotoxic activity within 
individual cells. Zinc excess is shown to induce 
lethargy and focal neuronal reduction. Zinc 
deficiency has been shown to induce lethargy, 
neurosensory pathology, neuropsychiatric 
disorders, and reduction of nerve conduction. 
Oral ingestion of toxic levels of zinc will produce 
symptoms of dizziness and lethargy. The 
inhalation of zinc can bring about shaking, 
fatigue, and fever. Although zinc acts as a 
neuromodulator, endogenous zinc can be a 
potent and rapid neurotoxin. At 300 µM levels, 
zinc will extensively destroy cortical cells in 
tissue culture. Neurons exposed to zinc will 
initiate apoptosis. The activity of zinc in the 
human body has significant implications for 
normal health. Zinc in excess or deficit will cause 
pathological conditions which should be rapidly 
diagnosed by clinicians.  Further study of the 
biological activity of zinc is warranted.  
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